// App-Quantinova.ai

e15252 : KRAS mutant circulating free DNA (cfDNA) and circulating tumor cell (CTC) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.

Researchers

Presenter

  • Carmen Guillen Ponce

Principal Investigators

  • Julie Earl

  • Sandra Garcia Nieto

  • Alfonso Sanjuanbenito

  • Mercedes Rodrguez Garrote

  • Eduardo Lisa

  • Elena Mend?a

  • Eduardo Lobo

  • Nuria Malats

Medical Centers

  • Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain

  • Ramon y Cajal University Hospital, Medical Oncology Department, Madrid, SpainHospital Universitario Ramon y Cajal, General Surgery Department., Madrid, SpainSurgery Department. Ramon y Cajal University Hospital,, Madrid, Spain

  • Complejo Hospitalario Universitario Albacete, Albacete, Spain

  • Genetic and Molecular Epidemiology Group, Spanish Cancer Research Cancer Center, Madrid, Spain

  • Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain

  • General and Digestive Surgery Department, Ramon y Cajal University Hospital, Madrid, Spain

  • CNIO - Spanish National Cancer Research Center, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Microphthalmia, syndromic, 9

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved